Free Trial

Bio-Rad Laboratories (BIO) Competitors

Bio-Rad Laboratories logo
$353.79 -6.75 (-1.87%)
As of 01/23/2025 03:58 PM Eastern

BIO vs. MTD, WAT, ILMN, TECH, BRKR, CRL, PACB, HBIO, TMO, and A

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bruker (BRKR), Charles River Laboratories International (CRL), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Bio-Rad Laboratories vs.

Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Mettler-Toledo International has a net margin of 21.15% compared to Bio-Rad Laboratories' net margin of -30.18%. Bio-Rad Laboratories' return on equity of 3.74% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories-30.18% 3.74% 2.65%
Mettler-Toledo International 21.15%-531.78%24.79%

65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 17.1% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Bio-Rad Laboratories has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.58B3.84-$637.32M-$27.33-12.95
Mettler-Toledo International$3.76B7.49$788.78M$37.0936.01

Bio-Rad Laboratories presently has a consensus target price of $394.20, indicating a potential upside of 11.42%. Mettler-Toledo International has a consensus target price of $1,351.25, indicating a potential upside of 1.16%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, research analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Mettler-Toledo International
1 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.11

Bio-Rad Laboratories received 2 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 64.92% of users gave Bio-Rad Laboratories an outperform vote while only 56.75% of users gave Mettler-Toledo International an outperform vote.

CompanyUnderperformOutperform
Bio-Rad LaboratoriesOutperform Votes
372
64.92%
Underperform Votes
201
35.08%
Mettler-Toledo InternationalOutperform Votes
370
56.75%
Underperform Votes
282
43.25%

In the previous week, Mettler-Toledo International had 6 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 11 mentions for Mettler-Toledo International and 5 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.38 beat Mettler-Toledo International's score of 1.31 indicating that Bio-Rad Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Rad Laboratories
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mettler-Toledo International
8 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 10 of the 18 factors compared between the two stocks.

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO vs. The Competition

MetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$10.09B$5.85B$5.43B$20.06B
Dividend YieldN/A0.40%5.36%3.60%
P/E Ratio-12.9527.2189.0641.55
Price / Sales3.844.491,228.0117.73
Price / Cash29.2342.4044.6520.44
Price / Book1.152.425.045.79
Net Income-$637.32M$2.94M$117.90M$1.01B
7 Day Performance2.68%1.30%3.02%1.98%
1 Month Performance7.74%3.17%4.34%5.82%
1 Year Performance12.23%-20.02%27.06%18.98%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIO
Bio-Rad Laboratories
4.1204 of 5 stars
$353.79
-1.9%
$394.20
+11.4%
+12.2%$10.09B$2.58B-12.958,030Positive News
MTD
Mettler-Toledo International
4.1443 of 5 stars
$1,295.77
-0.1%
$1,351.25
+4.3%
+9.5%$27.34B$3.79B34.9417,300Positive News
WAT
Waters
4.3835 of 5 stars
$403.85
-0.4%
$384.71
-4.7%
+30.4%$23.98B$2.96B38.547,900
ILMN
Illumina
4.6061 of 5 stars
$136.67
-0.5%
$165.63
+21.2%
-4.3%$21.68B$4.50B-13.729,300Analyst Revision
Positive News
TECH
Bio-Techne
4.1557 of 5 stars
$75.83
-0.4%
$82.00
+8.1%
+6.1%$12.05B$1.17B80.673,100
BRKR
Bruker
4.9616 of 5 stars
$56.88
-3.6%
$74.45
+30.9%
-19.1%$8.62B$3.24B27.359,707Analyst Revision
CRL
Charles River Laboratories International
4.6232 of 5 stars
$163.77
-1.2%
$209.00
+27.6%
-22.1%$8.37B$4.13B20.5021,800Analyst Downgrade
High Trading Volume
PACB
Pacific Biosciences of California
2.1216 of 5 stars
$1.64
+2.5%
$2.95
+80.2%
-76.5%$449.13M$200.52M-1.12730Analyst Forecast
Analyst Revision
News Coverage
Gap Down
HBIO
Harvard Bioscience
1.1564 of 5 stars
$1.93
+0.5%
N/A-60.1%$84.18M$97.73M-5.85490
TMO
Thermo Fisher Scientific
4.8482 of 5 stars
$559.72
-0.4%
$648.95
+15.9%
+4.4%$214.09B$42.86B35.09130,000Upcoming Earnings
Positive News
A
Agilent Technologies
4.68 of 5 stars
$147.57
+2.0%
$143.62
-2.7%
+15.8%$42.15B$6.51B33.3917,900Insider Trade
Positive News
High Trading Volume

Related Companies and Tools


This page (NYSE:BIO) was last updated on 1/24/2025 by MarketBeat.com Staff
From Our Partners